| 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | IC50 | 1400.0 [1] |
| 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Ki | 6000.0 [1] |
| 8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one | IC50 | 28.0 [1] |
| 8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one | Ki | 0.65 [1] |
| 2-(Morpholin-4-yl)-benzo[h]chromen-4-one | IC50 | 230.0 [1] |
| CID 11964036 | IC50 | 5.0 [1] |
| 2-(4-Morpholinyl)-4H-1-benzopyran-4-one | IC50 | 1260.0 [1], 1300.0 [2], 4300.0 [3], 10000.0 [4] |
| 2-(4-Methoxyphenyl)-6-morpholino-4H-pyran-4-one | IC50 | 220.0 [1] |
| 3-Morpholino-1H-benzo[f]chromen-1-one | IC50 | 1250.0 [1], 4000.0 [2] |
| 2-Morpholino-6-(4-methoxyphenyl)-4H-thiopyran-4-one | IC50 | 280.0 [1] |
| PI-103 | IC50 | 2.0 [1], 14.0 [2], 48.5 [3] |
| 6-[(E)-Hydrazinylidenemethyl]-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile | IC50 | 8000.0 [1], 100000.0 [2] |
| 2-Morpholino-4H-benzo[g]chromen-4-one | IC50 | 390.0 [1], 400.0 [2] |
| 2-(4-Chlorophenyl)-6-morpholin-4-yl-thiopyran-4-one | IC50 | 530.0 [1] |
| 2-(4-Chlorophenyl)-6-morpholino-4H-pyran-4-one | IC50 | 180.0 [1] |
| 2-Morpholino-6-phenyl-4H-pyran-4-one | IC50 | 1100.0 [1], 1300.0 [2] |
| 6-Methoxy-4-morpholin-4-yl-chromen-2-one | IC50 | 1200.0 [1], 1700.0 [2], 1750.0 [3] |
| 8-Dibenzofuran-4-yl-2-morpholin-4-ylchromen-4-one | IC50 | 40.0 [1], 41.0 [2] |
| 8-(Biphenyl-3-yl)-2-morpholino-4H-chromen-4-one | IC50 | 180.0 [1] |
| 2-Morpholino-6-phenyl-4H-thiopyran-4-one | IC50 | 650.0 [1], 720.0 [2] |
| Wortmannin | Ki | 120.0 [1] |
| Idelalisib | IC50 | 6700.0 [1] |
| 2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one | IC50 | 1800.0 [1], 2500.0 [2] |
| 3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide | IC50 | 26.0 [1], 4400.0 [2] |
| N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide | IC50 | 64.0 [1] |
| N-(7,8-Dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide | IC50 | 13.0 [1] |
| 2-Morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one | IC50 | 280.0 [1] |
| 4-Morpholin-4-yl-chromen-2-one | IC50 | 4800.0 [1], 4820.0 [2] |
| CID 46244454 | IC50 | 30000.0 [1] |
| 2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one | IC50 | 190.0 [1] |
| 8-Methoxy-2-morpholin-4-yl-chromen-4-one | IC50 | 1200.0 [1], 1800.0 [2] |
| 3-Amino-n,6-diphenylpyrazine-2-carboxamide | IC50 | 620.0 [1], 8000.0 [2] |
| 2-(4-Fluorophenyl)-6-morpholino-4H-pyran-4-one | IC50 | 350.0 [1] |
| 2-Thiomorpholino-4H-benzo[h]chromen-4-one | IC50 | 1380.0 [1] |
| 7-Methoxy-4-morpholin-4-yl-chromen-2-one | IC50 | 5400.0 [1], 11310.0 [2] |
| CID 11508681 | IC50 | 800.0 [1] |
| 8-Benzo[b]thiophen-2-yl-2-morpholin-4-yl-chromen-4-one | IC50 | 800.0 [1] |
| 2-Morpholin-4-yl-8-thiophen-2-ylchromen-4-one | IC50 | 700.0 [1] |
| 2-Morpholin-4-yl-8-thiophen-3-ylchromen-4-one | IC50 | 300.0 [1] |
| 8-(4-Hydroxymethylphenyl)-2-morpholin-4-ylchromen-4-one | IC50 | 600.0 [1] |
| 2-(4-(Benzo[b]thiophen-3-yl)phenyl)-6-morpholino-4H-thiopyran-4-one | IC50 | 160.0 [1], 330.0 [2] |
| 2-Morpholino-6-[4-(4-methyl-1-naphthyl)phenyl]-4H-thiopyran-4-one | IC50 | 260.0 [1] |
| 2-Morpholino-6-(3'-hydroxy-3-biphenylyl)-4H-thiopyran-4-one | IC50 | 920.0 [1] |
| 2-Morpholino-6-(3-bromophenyl)-4H-thiopyran-4-one | IC50 | 700.0 [1], 800.0 [2] |
| 2-Morpholino-6-(4-tert-butylphenyl)-4H-thiopyran-4-one | IC50 | 920.0 [1], 1100.0 [2] |
| 2-Morpholino-6-(4-bromophenyl)-4H-thiopyran-4-one | IC50 | 680.0 [1] |
| 6-(4-Methoxyphenyl)-2-morpholin-4-ylpyridin-4-ol | IC50 | 100000.0 [1] |
| Methyl (E)-3-[2-[3-(6-morpholin-4-yl-4-oxothiopyran-2-yl)phenyl]phenyl]prop-2-enoate | IC50 | 840.0 [1] |
| 2-(2-Methoxyphenyl)-6-morpholino-4H-pyran-4-one | IC50 | 310.0 [1], 380.0 [2] |
| 2-(3-Methoxyphenyl)-6-morpholino-4H-pyran-4-one | IC50 | 540.0 [1] |
| 2-Morpholino-6-(4-tert-butylphenyl)-4H-pyran-4-one | IC50 | 480.0 [1] |
| 4H-Naphtho(1,2-b)pyran-4-one, 2-(1-piperidinyl)- | IC50 | 3810.0 [1] |
| 8-(4-Methoxyphenyl)-2-(morpholin-4-yl)-4H-1-benzopyran-4-one | IC50 | 900.0 [1] |
| 4-Morpholino-7-(thiophen-2-yl)-2H-chromen-2-one | IC50 | 600.0 [1] |
| 3-Amino-6-[4-[1-(dimethylamino)propan-2-ylsulfonyl]phenyl]-N-phenylpyrazine-2-carboxamide | IC50 | 8000.0 [1] |
| 3-Amino-6-[4-[1-(dimethylamino)propan-2-ylsulfonyl]phenyl]-N-phenylpyrazine-2-carboxamide | Ki | 6.0 [1] |
| 2-Hydroxy-4-morpholin-4-yl-benzaldehyde | IC50 | 400.0 [1] |
| 2-Morpholino-6-(3-fluorophenyl)-4H-pyran-4-one | IC50 | 530.0 [1], 690.0 [2] |
| 2-Morpholino-6-[4-(1-naphthyl)phenyl]-4H-thiopyran-4-one | IC50 | 160.0 [1], 190.0 [2] |
| [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-[5-(2-morpholin-4-yl-4-oxochromen-7-yl)oxypentylamino]-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate | IC50 | 5000.0 [1], 10000.0 [2] |
| Caffeine | IC50 | 10000000.0 [1] |
| Gefitinib | IC50 | 50000.0 [1] |
| Sorafenib | IC50 | 50000.0 [1] |
| Suramin | IC50 | 1700.0 [1] |
| Trifluoperazine | IC50 | 100000.0 [1] |
| Sunitinib | IC50 | 50000.0 [1] |
| Dasatinib | IC50 | 50000.0 [1] |
| Vanillin | IC50 | 1500000.0 [1] |
| Flavone | IC50 | 10000.0 [1] |
| alpha-Naphthoflavone | IC50 | 4980.0 [1] |
| Tanespimycin | IC50 | 40000.0 [1] |
| Schisandrin B | IC50 | 1000000000.0 [1] |
| Pictilisib | IC50 | 1230.0 [1] |
| Buparlisib | IC50 | 6917.0 [1] |
| Torin 1 | IC50 | 6.34 [1] |
| Alpelisib | IC50 | 9100.0 [1] |
| 2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol | IC50 | 410.0 [1] |
| Ku-0063794 | IC50 | 10000.0 [1] |
| Torin 2 | IC50 | 0.5 [1] |
| N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide | IC50 | 150.0 [1] |
| Isogranulatimide | IC50 | 10000.0 [1] |
| Taselisib | IC50 | 4800.0 [1] |
| Imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane | IC50 | 30000.0 [1] |
| Pilaralisib | IC50 | 4800.0 [1] |
| DNA-PK Inhibitor III | IC50 | 120.0 [1] |
| CB-5083 | IC50 | 500.0 [1] |
| 1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 60.0 [1] |
| Leniolisib | IC50 | 880.0 [1] |
| N-[6-[6-Chloro-5-[[(4-fluorophenyl)sulfonyl]amino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide | IC50 | 3.0 [1] |
| 2-[[4-Amino-3-(3-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one | IC50 | 48000.0 [1] |
| 1-Tert-Butyl-3-Naphthalen-2-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine | IC50 | 420.0 [1] |
| CID 59604787 | IC50 | 8831.0 [1] |
| 2-Methyl-2-[4-(2-oxo-9-quinolin-3-yl-4H-[1,3]oxazino[5,4-c]quinolin-1-yl)phenyl]propanenitrile | IC50 | 36.0 [1] |
| 6-Nitroveratraldehyde | IC50 | 15000.0 [1] |
| (S)-2-(2-(2-Methylindolin-1-yl)-2-oxoethyl)-6-morpholinopyrimidin-4(3H)-one | IC50 | 2000.0 [1] |
| DNA-PK Inhibitor V | IC50 | 270.0 [1] |
| 3-Morpholino-5-phenylcyclohex-2-enone | IC50 | 10000.0 [1] |
| 2-Pyridin-4-yl-benzo[h]chromen-4-one | IC50 | 10000.0 [1] |
| 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine | IC50 | 10000.0 [1] |
| CID 118502708 | IC50 | 140.0 [1] |